Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
BioVentures Investors is a venture capital firm founded in 1998 and based in Westborough, Massachusetts. The firm focuses exclusively on the MedTech sector, aiming to address significant unmet needs in healthcare through investments in the development and commercialization of medical technologies. Over the past two decades, BioVentures Investors has built a reputation for trust, integrity, and performance, establishing itself as a key player in the healthcare investment landscape.
Currently, BioVentures Investors manages assets totaling between $145 million and $150 million across five funds. The firm has a diverse portfolio of 35 active companies, reflecting its commitment to supporting innovative solutions that improve patient outcomes and reduce healthcare costs. The firm operates two primary funds: the BioVentures MedTech Growth Capital Fund and the BioVentures MedTech Innovation Fund, which target different stages of company development.
BioVentures Investors primarily invests in emerging and growth-stage MedTech companies, with a focus on sectors such as next-generation implantable and disposable devices, tools, diagnostics, imaging, and healthcare IT. The firm seeks to capture investment opportunities that offer meaningful innovations and are positioned for acquisition. Their investment strategy emphasizes companies that have mitigated development and regulatory risks, ensuring a higher likelihood of success.
The firm typically deploys check sizes ranging from $3 million to $7 million, targeting companies that are entering growth phases or are in the development stage. BioVentures Investors aims to partner with companies that demonstrate potential for significant advancements in healthcare technology, ultimately leading to improved patient care and reduced costs.
BioVentures Investors has a diverse portfolio of 35 active MedTech investments, including:
Notable exits from their portfolio include Enanta Pharmaceuticals, Endotronix, and Zalicus, showcasing the firm's ability to identify and support successful MedTech ventures.
Marc Goldberg, JD, MBA - Co-Founder and Managing Partner. Goldberg has extensive experience in healthcare investing and management, having worked in the industry since 1984.
Peter Feinstein - Co-Founder and Venture Partner. Feinstein has collaborated with Goldberg on healthcare enterprises for decades, bringing a wealth of knowledge to the firm.
Walter Gilbert, PhD - Venture Partner. A Nobel Laureate in Chemistry, Gilbert has been involved with BioVentures Investors since its inception and adds significant scientific credibility.
Jeffrey Barnes, MS, MBA - Managing Director. Barnes has a strong background in healthcare technology and investment.
Tom Buttacavoli - Managing Director. Buttacavoli brings extensive experience in managing healthcare investments.
Jonathan Cohen - Keystone Partner. Cohen has a background in healthcare investment and strategy.
Donna Edmonds - Advisory Board. Edmonds provides strategic insights based on her extensive experience in the healthcare sector.
Jonathan P. Gertler, MD - Managing Director. Gertler has a medical background and expertise in healthcare investments.
James Lousararian, JD - Managing Director. Lousararian has a legal background and experience in healthcare investments.
Stephen Liu, MD - Venture Partner. Liu brings medical expertise to the investment team.
Chris Thompson - Keystone Partner. Thompson has a background in healthcare investment.
To pitch BioVentures Investors, founders should use the contact email info@bioventuresinvestors.com or visit their website at bioventuresinvestors.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, competitive landscape, and financial projections. Response times may vary, but founders should expect a thorough review process.
In July 2024, BioVentures Investors successfully exited its investment in Endotronix, a company focused on heart failure management solutions. This exit marks a significant milestone for the firm, showcasing its ability to identify and support successful MedTech ventures.
BioVentures Investors has also been active in maintaining a diverse portfolio of 35 companies, reflecting its commitment to the MedTech sector. The firm continues to seek new investment opportunities in innovative healthcare technologies.
What are BioVentures Investors' investment criteria?
BioVentures Investors focuses on emerging and growth-stage MedTech companies that offer innovative solutions in sectors such as implantable devices, diagnostics, and healthcare IT. They look for companies that have mitigated development and regulatory risks and are positioned for acquisition.
How can I pitch to BioVentures Investors?
Founders can pitch BioVentures Investors by visiting their website at bioventuresinvestors.com or by emailing them at info@bioventuresinvestors.com. It is advisable to include a detailed business plan and financial projections in the pitch.
What makes BioVentures Investors different from other VCs?
BioVentures Investors has a strong focus on the MedTech sector and a proven track record of successful investments. Their team includes a Nobel Laureate, which adds significant scientific credibility to their investment decisions.
What is the typical check size for investments?
The firm typically invests between $3 million and $7 million per company, depending on the stage of development and the specific needs of the business.
What is the geographic focus of BioVentures Investors?
BioVentures Investors primarily focuses on companies based in the United States, allowing them to leverage their extensive network and industry knowledge within the region.
What kind of support do portfolio companies receive?
BioVentures Investors provides extensive support to its portfolio companies through its deep industry knowledge, strong network, and the scientific credibility of its team members. This includes mentorship, operational support, and assistance with commercialization strategies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.